Brief: Unicycive Therapeutics Announces Second Quarter 2026 Financial Results And Provides Business Update
12/08/2026 12:37
BRIEF-Unicycive Therapeutics Announces Second Quarter 2026 Financial Results And Provides Business Update Aug 12 (Reuters) - Unicycive Therapeutics Inc UNCY.O:
UNICYCIVE THERAPEUTICS ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
UNICYCIVE THERAPEUTICS - Q2 NET LOSS WAS $1.70 MILLION OR $0.06 PER SHARE
Source text: ID:nGNXb4whq1
Further company coverage: UNCY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unicycive Therapeutics
See all newsBrief: Unicycive Therapeutics Appoints Meredith Manning To Board Of Directors
Brief: Unicycive Therapeutics Announces Resubmission Of New Drug Application For Oxylanthanum Carbonate
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
Unicycive rises on narrower quarterly loss